ClinicalTrials.Veeva

Menu

Time-specific Exercise in Circadian Context (CAEx)

C

Comenius University

Status

Active, not recruiting

Conditions

Osteoporosis
Osteopenia
Aging

Treatments

Procedure: Combined training

Study type

Interventional

Funder types

Other

Identifiers

NCT06746649
APVV-21-0164

Details and patient eligibility

About

The project aims to explore the mechanisms, by which physical activity can support healthy ageing and decrease the negative impact of ageing on the circadian system, musculoskeletal system and immunity.

Full description

The main aim of the project is to examine the effect of as well as of the three-month, timely specific training intervention on the functionality of circadian organization in elderly volunteers. The additive aim is to examine the effect of lifelong endurance physical activity, along with the experimental training intervention on the body composition, bone density, and selected hormonal, biochemical, histological and molecular indicators of metabolic health.

Partial aims are as follows:n to explore the effect of morning and afternoon training on the most significant parameters, identified by the previous cross-sectional study, in sedentary elderly. Furthermore, to clarify adaptation mechanisms of experimental training protocol on selected parameters, that may explain possible differences in mechanisms of active and passive aging.

Enrollment

34 patients

Sex

All

Ages

65 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • no history of regular physical activity training and exercise of more than 150 minutes of moderate or 75 minutes of higher intensity per week.
  • Body mass index (BMI) between 18.5 and 30 kg/m2 for all groups

Exclusion criteria for probands will be:

  • Recent or current infection, physical disability,
  • malignant, cardiovascular, metabolic, autoimmune diseases,
  • Malnutrition and pharmacological interference (e.g., steroids, non-steroidal anti-inflammatory agents, immunosuppressive and antineoplastic drugs).

Use of performance enhancing drugs in the past and during the study period will condition exclusion.

Exclusion criteria

  • recent or current infection, physical disabilities,
  • malignant, cardiovascular, metabolic, autoimmune diseases,
  • Malnutrition and pharmacological interference (e.g., steroids, nonsteroidal anti-inflammatory agents, immunosuppressive and antineoplastic drugs).

Use of performance-enhancing drugs in the past and during the study period will condition exclusion.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

34 participants in 3 patient groups

Morning group
Experimental group
Description:
The experimental factor will be applied in the morning (8:00-9:00).
Treatment:
Procedure: Combined training
Afternoon group
Experimental group
Description:
The experimental factor will be applied in the afternoon (16:00-17:00).
Treatment:
Procedure: Combined training
Control group
No Intervention group
Description:
None expertimental factor will be aplied

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems